Search research articles
Contact Us
Filters
Showing results (291-300 of 587) with videos related to
Page
of 59
Sort By:
Diabetes, Obesity & Metabolism
|
January 12, 2017
Efficacy and safety of fixed-dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trial
Linong Ji, Ling Li, Jian Kuang, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
April 13, 2022
Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus
Stefan Pleus, Guido Freckmann, Sebastian Schauer, et al.
Diabetes Technology & Therapeutics
|
October 9, 2015
Treatment Patterns and Glycemic Control in Older Adults with Type 2 Diabetes Mellitus Receiving Only Oral Antidiabetes Drugs in China
Lihua Zhang, Linong Ji, Lixin Guo, et al.
Journal of Diabetes Research
|
January 17, 2022
A Randomized Controlled Clinical Trial of Lifestyle Intervention and Pioglitazone for Normalization of Glucose Status in Chinese with Prediabetes
Yingying Luo, Hongyuan Wang, Xianghai Zhou, et al.
Journal of Diabetes Investigation
|
May 21, 2014
Efficacy and safety of exenatide once-weekly vs exenatide twice-daily in Asian patients with type 2 diabetes mellitus
Linong Ji, Yukiko Onishi, Chul Woo Ahn, et al.
Clinical Proteomics
|
May 23, 2017
The serum protein responses to treatment with Xiaoke Pill and Glibenclamide in type 2 diabetes patients
Xiuying Zhang, Haidan Sun, Sanjoy K Paul, et al.
Journal of Diabetes Research
|
February 8, 2017
Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes
Yingying Luo, Sanjoy K Paul, Xianghai Zhou, et al.
Clinical Therapeutics
|
January 3, 2015
Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis
Feng Sun, Shanshan Wu, Jing Wang, et al.
Advances in Therapy
|
February 10, 2025
Real-World Multicenter Registry to Determine Management and Quality of Care of Patients with Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases in China (iCaReMe China)
Xiaoling Cai, Wenjia Yang, Bo Feng, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
November 8, 2019
Prevalence and identification of type 1 diabetes in Chinese adults with newly diagnosed diabetes
Xiaohan Tang, Xiang Yan, Houde Zhou, et al.
Page
of 59
Search research articles
Search
Showing results (291-300 of 587) with videos related to
Sort By:
Page
of 59
Diabetes, Obesity & Metabolism
|
January 12, 2017
Efficacy and safety of fixed-dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trial
Linong Ji, Ling Li, Jian Kuang, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
April 13, 2022
Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus
Stefan Pleus, Guido Freckmann, Sebastian Schauer, et al.
Diabetes Technology & Therapeutics
|
October 9, 2015
Treatment Patterns and Glycemic Control in Older Adults with Type 2 Diabetes Mellitus Receiving Only Oral Antidiabetes Drugs in China
Lihua Zhang, Linong Ji, Lixin Guo, et al.
Journal of Diabetes Research
|
January 17, 2022
A Randomized Controlled Clinical Trial of Lifestyle Intervention and Pioglitazone for Normalization of Glucose Status in Chinese with Prediabetes
Yingying Luo, Hongyuan Wang, Xianghai Zhou, et al.
Journal of Diabetes Investigation
|
May 21, 2014
Efficacy and safety of exenatide once-weekly vs exenatide twice-daily in Asian patients with type 2 diabetes mellitus
Linong Ji, Yukiko Onishi, Chul Woo Ahn, et al.
Clinical Proteomics
|
May 23, 2017
The serum protein responses to treatment with Xiaoke Pill and Glibenclamide in type 2 diabetes patients
Xiuying Zhang, Haidan Sun, Sanjoy K Paul, et al.
Journal of Diabetes Research
|
February 8, 2017
Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes
Yingying Luo, Sanjoy K Paul, Xianghai Zhou, et al.
Clinical Therapeutics
|
January 3, 2015
Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis
Feng Sun, Shanshan Wu, Jing Wang, et al.
Advances in Therapy
|
February 10, 2025
Real-World Multicenter Registry to Determine Management and Quality of Care of Patients with Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases in China (iCaReMe China)
Xiaoling Cai, Wenjia Yang, Bo Feng, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
November 8, 2019
Prevalence and identification of type 1 diabetes in Chinese adults with newly diagnosed diabetes
Xiaohan Tang, Xiang Yan, Houde Zhou, et al.
Page
of 59